Dépôt DSpace/Université Larbi Tébessi-Tébessa

Médicaments de l’insuffisance hépatique chez l’homme

Afficher la notice abrégée

dc.contributor.author AYMEN, Ghania
dc.date.accessioned 2022-04-04T10:55:28Z
dc.date.available 2022-04-04T10:55:28Z
dc.date.issued 2020
dc.identifier.uri http//localhost:8080/jspui/handle/123456789/2668
dc.description.abstract Drug-induced hepatotoxicity is a major public health problem, as it is the leading cause of liver failure. The objective of the work is to evaluate antioxidant status during drug-induced liver failure. Our study was conducted in the laboratory on 60 samples of subjects (men and women), of which 30 subjects represents the control group and 30 subjects with drug-induced hepatic insufficiency, to which we have determined the following biochemical blood parameters: glucose, urea , creatinine, direct and state bilirubin, proteins, albumin, cholesterol, transaminases, alkaline phosphatase, reduced glutathione, glutathione peroxidase, glutathioneS-transferase, malondialdehyde. Analysis of the results confirmed liver failure with depletion of plasma antioxidant defense and increased lipid peroxidation It can be concluded that the severity of the disease is probably due to the decrease of antioxidant defense, and drugs likely to cause liver failure should be administered in combination with antioxidant molecules: trace elements (selenium, manganese, magnesium, zinc, copper ), vitamins (E, C, ..) en_US
dc.description.sponsorship Dr.BOUSSEKIN samira en_US
dc.language.iso fr en_US
dc.publisher Universite laarbi tebessi tebessa en_US
dc.subject liver failure, drugs, antioxidants, peroxidation, oxidative stress, biochemical balance. en_US
dc.subject : فشل الكبد ، المخدرات ، مضادات الأكسدة ، بیروكسید ، الإجھاد التأكسدي ، التوازن الكیمیائي الحیوي en_US
dc.title Médicaments de l’insuffisance hépatique chez l’homme en_US
dc.type Thesis en_US


Fichier(s) constituant ce document

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée